2024-10-30 - Analysis Report
## AbbVie Inc. (ABBV) Stock Analysis

**Company Overview:** AbbVie Inc. is a global pharmaceutical company that develops, manufactures, and markets a wide range of prescription drugs, primarily in the areas of immunology, oncology, neurology, and eye care.

**1. Performance vs. S&P 500:**

* **Cumulative Return (ABBV):** 146.24%
* **Cumulative Return (VOO):** 136.74%
* **Outperformance:** 9.5% 
* **Relative Outperformance:** 51.61% (This means that ABBV's performance has been in the top 51.61% of its historical performance against VOO).

**2. Recent Price Movement:**

* **Closing Price:** $189.45
* **5-day Moving Average:** $188.9
* **20-day Moving Average:** $191.58
* **60-day Moving Average:** $193.32

The stock is currently trading below its 5, 20, and 60-day moving averages, suggesting a potential downward trend. However, the gap between the current price and the moving averages is relatively small, indicating that the downtrend may be short-term.

**3. Technical Indicators:**

* **RSI:** 37.04 (Below 50, suggesting the stock is oversold)
* **PPO:** -0.13 (Negative, suggesting a potential downtrend)
* **Delta_Previous_Relative_Divergence:** -13.77 (Negative, suggesting a short-term downward trend)
* **Expected Return:** 3.02% (Represents the potential long-term (2 years or more) outperformance of ABBV compared to the S&P 500). 

**4. Recent Earnings and Outlook:**

| Date         | EPS   | Expected EPS |
|--------------|-------|--------------|
| 2024-07-25  | 2.65  | 2.57         |
| 2024-04-26  | 2.31  | 2.26         |
| 2024-02-02  | 2.79  | 2.76         |
| 2023-10-27  | 2.95  | 2.86         |
| 2023-07-27  | 2.91  | 2.79         |

The most recent earnings (2024-07-25) were above expectations, indicating a positive outlook for the company. However, the overall earnings trend has been slightly declining since 2023-10-27. 

**5. Financial Information:**

**Revenue and Profitability**

| Quarter      | Revenue  | Profit Margin |
|--------------|---------|---------------|
| 2024-06-30  | $14.46B | 70.94%         |
| 2024-03-31  | $12.31B | 66.74%         |
| 2023-12-31  | $14.30B | 60.11%         |
| 2023-09-30  | $13.93B | 53.44%         |
| 2023-06-30  | $13.87B | 69.42%         |

* **Revenue:** Shows a consistent growth pattern, except for a minor dip in Q1 2024. 
* **Profit Margin:** Fluctuated slightly but remains high, indicating strong profitability.

**Capital and Profitability**

| Quarter      | Equity   | ROE       |
|--------------|---------|------------|
| 2024-06-30  | $6.78B  | 20.21%     |
| 2024-03-31  | $8.01B  | 17.10%     |
| 2023-12-31  | $10.36B | 7.93%      |
| 2023-09-30  | $12.09B | 14.70%     |
| 2023-06-30  | $12.87B | 15.73%     |

* **Equity:** Experienced a dip in Q4 2023, but overall trends show a healthy balance sheet. 
* **ROE (Return on Equity):** Demonstrates a slightly volatile trend, but remains above average, indicating efficient utilization of shareholder funds.

**6. News and Recent Issues:**

(Please provide specific dates to analyze news from those dates. This information is not available within the current context.)

* **Earnings News:** Analyze news related to ABBV earnings releases for any significant information.
* **Recent Market Outlook:** Search for recent market analyses for ABBV, which may include expert opinions, market sentiment, and potential future growth scenarios.
* **Analyst Opinions and Performance Highlights:** Utilize resources like FINBOLD to gather a consensus of analyst opinions on the stock and assess performance highlights.

**7. Comprehensive Analysis:**

ABBV is a financially strong company with a history of consistent revenue growth and high profitability.  Recent earnings results were positive, exceeding expectations, and the stock is currently trading at a relative discount compared to its historical performance. However, technical indicators suggest a potential short-term downtrend, and the recent earnings trend has been slightly declining. 

**Overall:** The stock presents a mixed picture.  While the company's fundamentals remain strong, short-term price movements might indicate caution.  Consider the potential upside with the long-term outlook of ABBV's expected outperformance against the S&P 500 while monitoring the short-term trends closely.

**Note:** This analysis is based on the provided data and information. You should conduct further research and consider your own investment goals before making any investment decisions. 
